PSI Advisors’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-700
| Closed | -$21.1K | – | 932 |
|
|
2024
Q4 | $21.1K | Hold |
700
| – | – | 0.01% | 415 |
|
|
2024
Q3 | $16.4K | Sell |
700
-500
| -42% | -$11.7K | ﹤0.01% | 455 |
|
|
2024
Q2 | $21.3K | Buy |
1,200
+1,000
| +500% | +$17.8K | 0.01% | 392 |
|
|
2024
Q1 | $3.04K | Sell |
200
-1,000
| -83% | -$15.2K | ﹤0.01% | 642 |
|
|
2023
Q4 | $20.5K | Sell |
1,200
-75
| -6% | -$1.28K | 0.01% | 411 |
|
|
2023
Q3 | $10.7K | Hold |
1,275
| – | – | ﹤0.01% | 478 |
|
|
2023
Q2 | $31.7K | Hold |
1,275
| – | – | 0.01% | 315 |
|
|
2023
Q1 | $19.2K | Hold |
1,275
| – | – | 0.01% | 340 |
|
|
2022
Q4 | $15.1K | Hold |
1,275
| – | – | 0.01% | 367 |
|
|
2022
Q3 | $8K | Hold |
1,275
| – | – | ﹤0.01% | 469 |
|
|
2022
Q2 | $5K | Buy |
1,275
+1,000
| +364% | +$3.92K | ﹤0.01% | 579 |
|
|
2022
Q1 | $3K | Sell |
275
-1,000
| -78% | -$10.9K | ﹤0.01% | 603 |
|
|
2021
Q4 | $24K | Sell |
1,275
-825
| -39% | -$15.5K | 0.01% | 374 |
|
|
2021
Q3 | $70K | Buy |
+2,100
| New | +$70K | 0.03% | 242 |
|